The Immune Checkpoints CTLA-4 and PD-L1 in Carcinomas of the Uterine Cervix

ConclusionCTLA-4 and PD-L1 are potential therapeutic targets in cervical cancer.
Source: Pathology Research and Practice - Category: Pathology Source Type: research